It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Chemotherapy works by killing cancer cells

Chemotherapy drugs can't tell the difference between cell types, so cells that can fight infection, such as neutrophils, may also be killed during chemotherapy treatments.

Normal blood cells compared to Neutropenia (low neutrophil count).

Adapted with permission from Patel K et al. JAMA Oncol. 2017;3(12):1751.

When chemotherapy attacks healthy neutrophils (a type of white blood cell), the body is put at greater risk for infection because it has a weakened immune system. A low level of neutrophils is known as neutropenia. When combined with a fever, this condition is called febrile neutropenia.

Infections are a major risk for patients undergoing chemotherapy

Infection is a common complication of cancer treatment and can be life-threatening. An infection occurs when germs, such as bacteria or viruses, enter the body and multiply, which can cause illness, disease, or tissue damage. Alert your healthcare provider immediately if you think you may have an infection.

Protecting against the risk of infection
Protecting my body from infection

Protecting against the risk of infection

Neutropenia may occur in patients receiving chemotherapy, which can increase risk of serious infections. ZIEXTENZO helps protect against the risk of infection by boosting your white blood cell count.

References: 1. US Centers for Disease Control and Prevention. What you need to know: Neutropenia and risk for infection. Accessed June 12, 2023. 2. Patel K, West H. Febrile Neutropenia. JAMA Oncol. 2017;3(12):1751. doi:10.1001/jamaoncol.2017.1114. 3. ZIEXTENZO Prescribing Information. Sandoz Inc. March 2021.